[Cytostatic effect of 1-methyl-2-(p-(bis-(beta-chlorethyl)-amino)-phenyliminomethyl)-quinolinium chloride (IMET 3106) on the growth of transplantable neoplasms].
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D007097:Imines / Q000627:therapeutic use; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010954:Plasmacytoma / Q000188:drug therapy; D011806:Quinolinium Compounds / Q000627:therapeutic use; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy
D007097:Imines; D009588:Nitrogen Mustard Compounds; D011806:Quinolinium Compounds; C002147:IMET 3106
Die zytostatische Wirkung von 1-Methyl-2-(p-(bis-(beta-chloräthyl)-amino)-phenyliminomethyl)-chinolinium-chlorid (IMET 3106) auf das Wachstum von Transplantationstumoren.